H. Lundbeck A/S | Cash Flow

Fiscal year is January-December. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,599
99
6,816
2,292
4,408
5,301
Depreciation, Depletion & Amortization
-
-
1,366
1,342
-
-
Other Funds
1,082
1,071
6,181
971
654
120
Funds from Operations
2,681
1,170
731
2,663
3,754
5,421
Changes in Working Capital
1,079
440
534
463
291
563
Net Operating Cash Flow
3,760
1,610
197
3,126
4,045
5,984
Capital Expenditures
1,515
1,549
2,956
342
725
Sale of Fixed Assets & Businesses
5
8
12
8
404
Purchase/Sale of Investments
10
976
5
3
-
Net Investing Cash Flow
1,500
3,396
2,842
337
1,830
Cash Dividends Paid - Total
392
544
-
-
483
Issuance/Reduction of Debt, Net
251
1,182
421
1,888
1,873
Net Financing Cash Flow
141
589
501
2,006
2,235
Net Change in Cash
2,070
1,166
2,147
696
45
Free Cash Flow
3,449
1,370
40
2,888
3,800
Net Assets from Acquisitions
-
2,831
-
-
-
Other Sources
-
-
107
-
-
Change in Capital Stock
-
49
80
118
121
Exchange Rate Effect
49
31
3
87
25
Other Uses
-
-
-
-
1,509

About H. Lundbeck A/S

View Profile
Address
Ottiliavej 9
Valby CR 2500
Denmark
Employees -
Website http://www.lundbeck.com
Updated 07/08/2019
H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets.